is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Detailed information on Novavax, Inc. required for business and competitor intelligence needs
A study of the major internal and external factors affecting Novavax, Inc. in the form of a SWOT analysis
An in-depth view of the business model of Novavax, Inc. including a breakdown and examination of key business segments
Intelligence on Novavax, Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Novavax, Inc., such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Novavax (or 'the company') is a biopharmaceutical company focused on developing recombinant vaccines. The company's technology platform is based on recombinant nanoparticle vaccine technology that includes virus-like particles (VLPs) and protein nanoparticles. Novavax operates in the US where it is headquartered in Rockville, Maryland. It employed 308 people as on February 23, 2015.
Reasons to Purchase:
Gain understanding of Novavax, Inc. and the factors that influence its strategies
Track strategic initiatives of the company and latest corporate news and actions
Assess Novavax, Inc. as a prospective partner, vendor or supplier
Support sales activities by understanding your customers' businesses better
Stay up to date on Novavax, Inc.’s business structure, strategy and prospects